Source: Pharamceutical Technology

VisualDx: Menarini to enhance BPDCN detection with VisualDx's link

Menarini Group has announced a partnership with VisualDx to enhance the diagnosis of individuals with BPDCN.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Art Papier's photo - Co-Founder & CEO of VisualDx

Co-Founder & CEO

Art Papier

CEO Approval Rating

87/100

Read more